NASDAQ:HBIO Harvard Bioscience Q2 2026 Earnings Report $6.27 -0.04 (-0.70%) As of 01:13 PM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast Harvard Bioscience EPS ResultsActual EPSN/AConsensus EPS -$0.21Beat/MissN/AOne Year Ago EPSN/AHarvard Bioscience Revenue ResultsActual RevenueN/AExpected Revenue$21.45 millionBeat/MissN/AYoY Revenue GrowthN/AHarvard Bioscience Announcement DetailsQuarterQ2 2026Date8/11/2026TimeBefore Market OpensConference Call DateTuesday, August 11, 2026Conference Call Time8:00AM ETConference Call ResourcesEarnings HistoryCompany Profile Harvard Bioscience Earnings HeadlinesHarvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ETJuly 28, 2026 | globenewswire.comHBIO Share News TodayJuly 7, 2026 | uk.investing.comNew Dollar Plan Could Drain Your Account (Silently)Washington's so-called 'Mar-a-Lago Accord' aims to deliberately weaken the U.S. dollar to boost exports and bring jobs home. But there's a cost most officials won't mention at the podium. That $100,000 you've saved still shows the same number on your statement - but its purchasing power shrinks by design. Smart investors are already repositioning their wealth before the policy takes full effect.August 4 at 1:00 AM | Priority Gold (Ad)Harvard Bioscience Shareholders Expand Equity Plans, Elect DirectorsJune 2, 2026 | tipranks.comHarvard Bioscience Balances Margin Gains With Soft SalesMay 19, 2026 | tipranks.comHBIO Q1 2026 Earnings TranscriptMay 14, 2026 | finance.yahoo.comSee More Harvard Bioscience Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Harvard Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Harvard Bioscience and other key companies, straight to your email. Email Address About Harvard BioscienceHarvard Bioscience (NASDAQ:HBIO) develops, manufactures and distributes life science research instruments and consumables used by academic, biopharmaceutical and government laboratories worldwide. The company’s product portfolio spans cellular physiology, microfluidics, electrophysiology and lab automation, providing tools that enable researchers to study everything from cell behavior and organ function to drug delivery and tissue mechanics. Through its operating units—most notably Harvard Apparatus, BTX, Radnoti and Warner Instruments—Harvard Bioscience offers a diverse range of scientific equipment including precision pumps, stereotaxic instruments, electroporation and gene delivery systems, perfusion systems and microinjection tools. The company serves its customers via direct sales and an extensive distributor network, with significant operations in North America, Europe and the Asia‐Pacific region. Founded in 1901 and headquartered in Holliston, Massachusetts, Harvard Bioscience has grown through organic innovation and strategic acquisitions to support the evolving needs of life science research. The company maintains manufacturing and R&D facilities in the United States and Europe and is managed by an experienced team of professionals with backgrounds in engineering, sales and scientific product development.View Harvard Bioscience ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles The AI Chip Stock Making a Quiet Move Toward DominanceApple’s AI Strategy Looks Different—Will It Pay Off?Why Walmart and Amazon Could Be the Market’s Most Complementary Mega-CapsDodging Deutsche Telekom: T-Mobile's Strategic WinSpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have ControlTyson Foods Offers a Meaty Opportunity for Income InvestorsStrategy's Structural Strength: Hidden in a $8 Billion Illusion Upcoming Earnings DoorDash (8/5/2026)Walt Disney (8/5/2026)MercadoLibre (8/5/2026)Occidental Petroleum (8/5/2026)Phillips 66 (8/5/2026)Allstate (8/5/2026)Brookfield Asset Management (8/5/2026)MetLife (8/5/2026)Manulife Financial (8/5/2026)Block (8/5/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
